Lexicon Pharmaceuticals
  • Home
  • Contact Us
  • Site Map
  • About Us
    • About Us Home
    • Management Team
    • Board of Directors
    • Development Team
    • Locations
    • Contact Us
    • History
  • Pipeline
    • Drug Pipeline Home
    • Our Goal
    • Therapeutic Areas
    • Drug Development Team
    • Clinical Trials
    • Publications
  • Discovery
    • Discovery Home
    • Discovery Process
    • Technology
    • Genome5000
    • Medicinal Chemistry
    • Patents
    • Academic Access
    • Technology Licensing
    • Scientific Publications
  • Alliances
    • Alliances Home
    • Current Alliances
    • Technology Licensing
  • Careers
    • Careers Home
    • Opportunities
    • Our Culture
    • Benefits
    • Community Involvement
    • The Woodlands
    • Princeton
    • Awards and Recognition
  • News
    • News Home
    • Media Inquiries
  • Investors
    • Investors Home
    • Media
    • Events
    • Stock Quote
    • SEC Filings
    • Annual Reports
    • Corporate Governance
    • Request Information
Lexicon Banner
  • News Home
  • Media Inquiries
Subscribe
Press Releases
Filter     Display # 
03/07/2010 Lexicon Announces Proposed $95 Million Common Stock Offering
02/23/2010 Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2009 Fourth Quarter And Full Year Financial Results
02/16/2010 Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
02/03/2010 Lexicon Pharmaceuticals to present at the 12th Annual BIO CEO & Investor Conference
01/26/2010 Lexicon to host conference call and webcast to review top-line phase 2 results from diabetes trial
01/19/2010 Phase 2 trial of LX4211 demonstrates significant and rapid improvements in multiple parameters in type 2 diabetic patients
11/23/2009 Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
11/12/2009 Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
10/27/2009 Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Third Quarter Financial Results
10/20/2009 Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2009 Financial Results on October 27, 2009
 
«StartPrev12345678910NextEnd»
Page 1 of 36
  • About Us
  • Pipeline
  • Discovery
  • Alliances
  • Careers
  • News
  • Investors
  • Terms Of Use

Copyright © 2009, Lexicon Pharmaceuticals, Inc. All rights reserved.